Page last updated: 2024-09-03

n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and mdl 72527

n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine has been researched along with mdl 72527 in 1 studies

Compound Research Comparison

Studies
(n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine)
Trials
(n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine)
Recent Studies (post-2010)
(n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine)
Studies
(mdl 72527)
Trials
(mdl 72527)
Recent Studies (post-2010) (mdl 72527)
140084013

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casero, RA; Ha, HC; Woster, PM; Yager, JD1

Other Studies

1 other study(ies) available for n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and mdl 72527

ArticleYear
The role of polyamine catabolism in polyamine analogue-induced programmed cell death.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Oct-14, Volume: 94, Issue:21

    Topics: Acetyltransferases; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catalase; DNA Fragmentation; DNA, Neoplasm; Humans; Lung Neoplasms; Oxidoreductases Acting on CH-NH Group Donors; Polyamines; Putrescine; Tumor Cells, Cultured

1997